Syntaxin raises £18 million
Biotechnology company Syntaxin has raised £18 million to further develop its technology and start clinical studies on one of its products.
News
Biotechnology company Syntaxin has raised £18 million to further develop its technology and start clinical studies on one of its products.
News
Partner content
Accounting and Finance Software
Accounting and Finance Software